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Objectives. We sought to identify the clinical characteristics
associated with, and to investigate the impact of cohort selection
criteria on, interracial use of invasive cardiac procedures and to
determine survival.
Background. Although interracial differences in the use of
invasive cardiac procedures have been previously reported, the
underlying reasons are not known.
Methods. A retrospective cohort study was conducted at a
Veterans Affairs Medical Center. Study patients were evaluated
for cardiovascular disease between January 1 and December 31,
1993.
Results. The study included 1,406 male patients (85% white,
58% married), with a mean age of 63.4 years. African Americans
were less likely than whites to undergo procedures (cardiac
catheterization: odds ratio [OR] 0.37, 95% confidence interval
[CI] 0.24 to 0.58; coronary angioplasty: OR 0.60, 95% CI 0.25 to
1.49; coronary bypass surgery: OR 0.22, 95% CI 0.08 to 0.63; any
procedure: OR 0.32, 95% CI 0.21 to 0.50). On bivariate analysis,
patients who underwent cardiac procedures were more likely to be
younger, married and reside nonlocally and less likely to have
severe comorbid disease; however, African Americans were less
likely to be married and to reside nonlocally and more likely to
have severe comorbid disease. Cohorts adjusting for referral
status and specified cardiac diagnoses reduced or reversed inter-
racial treatment differences. Thirty-day and 1-year survival rates
(96% and 87.6%, respectively) were equivalent.
Conclusions. Racial disparity in invasive cardiac procedure use
may be partially explained by clinical differences and cohort
selection bias. Despite treatment differences, survival rates were
equivalent in African Americans and whites.
(J Am Coll Cardiol 1997;30:1707–13)
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Despite significant advances in diagnostic and therapeutic
interventions during the past two decades, ischemic heart
disease (IHD) continues to be the leading cause of mortality in
the United States (1). Use of invasive cardiac procedures for
evaluating and managing this disease has been shown to
improve patient outcomes (2); however, these technologies
have not been used uniformly among all ethnic populations.
Several investigators using administrative data bases, within
and outside the Department of Veterans Affairs (DVA), have
observed consistent and dramatic racial differences in the
utilization of invasive procedures for the evaluation and treat-
ment of cardiovascular disease (CVD) (3–12). Specifically,
cardiac catheterization (CC), percutaneous transluminal coro-
nary angioplasty (PTCA) and coronary artery bypass graft
surgery (CABG) appear to be performed less often in African
Americans than in whites. However, these studies’ reliance on
administrative data bases precludes a complete understanding
of the reasons for observed racial differences. Importantly,
these administrative data bases have lacked clinically relevant
data necessary to adjust for the effects of comorbid conditions
and disease severity on invasive cardiac procedure use.
Previous studies using administrative data bases have at
least two other limitations, as well: 1) They failed to account
for patients who may have been admitted to the hospital
exclusively for the purpose of undergoing cardiac procedures.
To the extent that white patients in these cohorts may have had
a higher proportion of elective cardiac admissions, observed
rates of inpatient cardiac procedures may have been biased
toward higher utilization among whites (3–12). 2) Previous
research has focused on either patient groups with a single
cardiac diagnosis (e.g., acute myocardial infarction) (3) or
heterogeneous diagnoses that include noncardiac diseases
(e.g., aortic aneurysm) (4). These extremes in disease criteria
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may have been too restrictive or too generalized to encompass
the true clinical spectrum of IHD.
We sought to determine whether racial variation was
present at our institution with regard to the use of CC, PTCA
and CABG and to determine whether these treatment differ-
ences impacted on survival by replicating the methods of
previous research within the DVA (4). In addition, we sought
to extend research in this area by performing a pilot study to
investigate the role of 1) critical clinical factors unavailable in
administrative data bases; and 2) cohort selection criteria that
would control for a) referred admissions and b) specified IHD
diagnoses.
Methods
Study sites. This study was conducted at the Roudebush
Veterans Affairs Medical Center (VAMC), a 400-bed, medical-
surgical hospital that provides both primary and tertiary care.
At the time of this study, this institution provided care to
;6,600 veterans in the outpatient clinics and emergency room
per year, with ;7,600 patients discharged from the hospital
annually. In addition to the DVA’s inpatient administrative
data base—Patient Treatment File (PTF)—the Roudebush
VAMC uses a locally developed MUMPS-based version of the
Regenstrief Medical Record System (RMRS) (13). The
RMRS stores longitudinal data from the outpatient, emer-
gency room and inpatient settings, including health services
utilization, medication histories, clinical outcomes, results of
tests and procedures and diagnoses made in the outpatient or
inpatient setting (14). The study protocol was approved by the
institutional review board at the Indiana University Medical
Center, Indianapolis and the Roudebush VAMC.
Patient eligibility and identification. The CVD cohort
consisted of inpatients, identified by computerized audit, who
were discharged from the hospital between January 1 and
December 31, 1993 with a primary diagnosis of CVD or chest
pain (ICD-9-CM discharge codes 390-459 and 786.5-786.59
respectively; see Appendix). Eligibility criteria from a previous
investigation (4) within the DVA were applied: male gender
and age .30 years. Patients were excluded if they were
ineligible for DVA care or received an invasive cardiac proce-
dure within 90 days before index hospital admission, or if race
was coded as other than African American or white. For all
patients, the index event was defined as the first hospital
admission for one of the target conditions during the study
period.
Measures. Our primary dependent variable, invasive car-
diac procedure use within prespecified periods after the index
event (60 days for CC and PTCA, 90 days for CABG), was
identified by computerized audit. For each relevant ICD-9-CM
procedure code (see Appendix), we recorded the occurrence
and date of each CC, PTCA and CABG. We then determined
utilization for each invasive cardiac procedure category (indi-
vidual patients could have contributed only once to each
procedure category), as well as utilization of any cardiac
procedure (individual patients could have contributed only
once to any procedure category) during the specified periods.
Independent variables were assessed using three sources.
Computerized audits of the PTF were used to obtain patient
age, race, gender, marital status, entitlement status (a variable
derived from the patient’s service-connection status, which can
affect access to outpatient care) and county of residence.
Audits of the RMRS were used to identify conditions present
before and during the index hospital admission that might
make aggressive management of coronary artery disease less
likely (see Appendix) (4). The RMRS was also used to
supplement these data by determining whether additional
comorbid diagnoses were present (e.g., stroke and congestive
heart failure) and by obtaining measures of disease severity
(e.g., laboratory assessments of renal and hepatic function,
echocardiographic assessments, spirometry assessments) un-
available in the administrative data base. Finally, manual chart
audits were used to collect additional clinical data that were
unavailable in RMRS and PTF but were specified, a priori, as
factors that might influence the management of coronary
artery disease. These variables included initial therapies (in-
cluding use of thrombolytic agents, intravenous nitroglycerin
and intravenous heparin), patient refusal of recommended
therapies and follow-up plans for those patients discharged
from the hospital before performance of procedures. Chart
audits were performed by senior medical students who had no
knowledge of the study objectives and who demonstrated
.90% agreement after baseline training and throughout the
audit process.
Our secondary dependent variable, survival, was deter-
mined for two periods after the index hospital admission
date—30 days and 1 year. Survival data were obtained through
the Beneficiary Identification and Record Locator System.
Statistical analysis. To examine factors associated with
invasive cardiac procedure use, we used t tests for continuous
variables and either the Fisher exact test or the chi-square test
for categoric data. These general approaches were applied to
three patient cohorts (Fig. 1). To determine whether racial
variation existed among inpatients at our VAMC, we formed
the CVD cohort using ICD-9-CM discharge codes that were
identical to a previously published investigation within the
DVA (4). Two additional cohorts were subsequently formed to
examine potential bases for observed racial variation: 1) Be-
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CC 5 cardiac catheterization
CVD 5 cardiovascular disease
DVA 5 Department of Veterans Affairs
IHD 5 ischemic heart disease
OR 5 odds ratio
PTCA 5 percutaneous transluminal coronary angioplasty
PTF 5 patient treatment file
RMRS 5 Regenstrief Medical Record System
VAMC 5 Veterans Affairs Medical Center
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cause the Roudebush VAMC is a tertiary medical center, many
patients undergo elective cardiac procedures at this facility
while receiving their primary and acute care elsewhere. Thus,
the local cohort represented veterans who resided in Marion
County (Indianapolis). 2) Because the CVD cohort included
ICD-9-CM discharge codes that may not reflect IHD, the IHD
cohort used restricted discharge codes to identify patients with
a narrower spectrum of diagnoses (i.e., acute myocardial
infarction [410-410.92], unstable angina [411-411.89], angina
[413-413.9] or chronic ischemia [414.0, 414.8, 414.9]).
We used the Fisher exact test to compare 30-day and 1-year
survival between African Americans and whites in the CVD
cohort.
Results
Study cohorts. We identified 1,437 veterans who were
admitted with CVD diagnoses, 1,406 of whom (98%) remained
eligible for the CVD cohort. Computerized audits (PTF and
RMRS) were conducted for all patients. Chart audits were
performed in 1,043 of eligible patients (74%). Reasons for not
performing a chart audit were that 311 charts (22%) could not
be obtained from referral medical centers and 52 local charts
(4%) could not be located after three requests. The refined
cohorts contained 511 inpatients whose primary residence
allowed inclusion in the local cohort and 497 inpatients whose
primary diagnoses allowed inclusion in the IHD cohort.
The demographic characteristics of the patients in our
cohorts are shown in Table 1. African Americans comprised
15% of the CVD cohort, 33% of the local cohort and 8% of the
IHD cohort.
Invasive cardiac procedure use. Cardiovascular disease co-
hort. As in previous studies, the unadjusted analyses revealed
that African Americans were less likely than whites to have CC
performed during or within 60 days of the index hospital
admission (odds ratio [OR] 0.37), CABG within 90 days of the
index hospital admission (OR 0.22) or any cardiac procedure
within the specified interval (OR 0.32) (Table 2). There was no
statistical difference in the use of PTCA (OR 0.60) within 60
days of the index hospital admission.
Demographic and clinical variables associated with procedure
use. Demographically, patients who received cardiac proce-
dures were significantly younger and more likely to be married,
be non-service connected for DVA care and reside outside of
Marion County than those who did not receive procedures
(Table 3). Clinically, patients were more likely to receive
invasive cardiac procedures if they had not previously received
CABG; did not have comorbid diagnoses of congestive heart
failure, cerebrovascular disease, renal disease, ascites, diabetes
mellitus or malignancy; were discharged from the hospital
(index admission) with plans to later receive invasive cardiac
procedures; and had lower disease severity, as measured by
chest X-ray film criteria, serum blood urea nitrogen and
creatinine, 24-h creatinine clearance estimates, serum albumin,
pulmonary function testing and ideal body weight (Table 3).
Because of the small number of African American patients
receiving cardiac procedures, multivariate analyses controlling
for race and clinical variables could not be performed. How-
ever, comparison of these clinical variables by race is described
next.
Demographic and clinical variable comparisons between
African Americans and whites are shown in Table 4. Demo-
graphically, African Americans were less likely than whites to
be married, be non-service connected for DVA care and reside
outside Marion County. Clinically, African Americans were
more likely to have diagnoses of lung cancer, schizophrenia,
dementia, renal disease and diabetes mellitus. African Amer-
icans also had higher disease severity, as measured by serum
blood urea nitrogen and creatinine, estimated creatinine clear-
ance, serum albumin, pulmonary function testing and ideal
body weight.
Figure 1. CVD cohort and refined cohorts.
Table 1. Demographic Characteristics of Cardiovascular Disease
Cohort and Refined Cohorts
CVD
Cohort
(n 5 1,406)
Local Cohort
(n 5 511)
IHD Cohort
(n 5 497)
Mean age (yr) 63.4 61.8 57.4
Married (%) 58 50 64
Race (%African American) 15 33 8
Eligibility status (%)
Service connected 16 25 30
Non-service connected 32 48 54
Primary diagnosis (%)
Acute MI 8 7 21
Unstable angina 5 4 13
Angina 1 1 2
Chronic ischemia 22 16 64
Chest pain 9 11 0
Other diagnoses 56 60 0
CVD 5 cardiovascular disease; IHD 5 ischemic heart disease; MI 5
myocardial infarction.
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Refined cohorts. Among the 511 patients in the local co-
hort, the unadjusted OR of undergoing CC, PTCA, CABG or
any procedure was 0.47, 1.11, 0.30 and 0.46, respectively, for an
African American compared with a white veteran (Table 2).
Among the 497 patients in the IHD cohort: the unadjusted
odds ratio for undergoing CC, PTCA, CABG or any procedure
was 0.70, 1.36, 0.45 and 0.55, respectively for African Ameri-
cans versus whites (Table 2).
Survival. Comparison of survival between African Ameri-
can and white patients in the CVD cohort revealed nearly
equivalent 30-day and 1-year survival rates (95% vs. 96%
[OR 5 0.75] and 84% vs. 88% [OR 0.73], respectively) (Table
5). Comparison of survival rates among patients in the addi-
tional cohorts revealed similar results (data not shown).
Discussion
Although we confirmed previously observed interracial
differences in the use of invasive cardiac procedures among our
nation’s veterans (3,4), we extended the research by examining
issues not previously explored:
1. We studied demographic and clinical factors associated
with procedure use among patients in our cohort. We found
that patients who received invasive cardiac procedures were
more likely to be younger, married, and non-service connected
for DVA care than those who did not receive procedures.
These demographic differences have been observed by other
researchers, and when controlled for in multivariate analyses,
racial differences persisted. More importantly, when using the
clinical data base, we found that patients who received proce-
dures had fewer prespecified comorbid conditions and had
lower noncardiac disease severity measures. We speculate that
the presence and severity of these comorbid conditions may
have had an impact on physicians’ clinical decision-making
regarding use of invasive cardiac procedures, because aggres-
sive medical care is often restricted to those without concur-
rent severe or life-threatening comorbid conditions. When we
studied these same factors in terms of race, African Americans
were less likely to have clinical attributes associated with
procedure use. However, because of the small sample size of
African Americans receiving procedures in our cohort, we
could not perform the necessary multivariate analyses to
control for race and these clinical factors.
2. Previous studies have not adjusted for the effect of
patient referral on the use of invasive cardiac procedures.
When examining demographic factors among patients in the
CVD cohort, we found that patients residing outside of Marion
County were more likely to receive cardiac procedures and
that African American patients were less likely to reside
outside Marion County. This association was supported in the
following additional analyses. We found that restricting our
cohort to include only patients who received their primary care
at this institution (local cohort) partially mitigated the ob-
served racial differences between CC and CABG use while
reversing the racial difference in PTCA use. A plausible
explanation for this finding may be that rural Indiana popula-
tions, which are predominantly white, sought local medical
care for early and acute symptoms of cardiac disease, and only
after preliminary evaluation at these sites suggested severe
cardiac disease were they referred for more invasive proce-
dures. Thus, whites from these areas who were judged to have
less severe cardiac disease and who were not referred to
receive invasive cardiac procedures at this institution were
not eligible for study inclusion. Therefore, previous studies
that have examined inpatients at tertiary medical centers
may have been similarly influenced by selecting patient
groups with differing racial patterns for primary and re-
ferred medical care.
3. Refining our analyses to only patients with specified IHD
diagnoses (IHD cohort) reduced racial differences for CC and
CABG and reversed the racial difference for PTCA. Two
factors may explain these findings: a) By limiting eligible
diagnoses to IHD, we may have eliminated the influence of
confounding conditions that also predispose patients to receive
invasive cardiac procedures. For example, patients being con-
sidered for noncardiac operations often undergo extensive
preoperative evaluation before elective operation. Given the
broad nature of these predisposing diagnoses, such as periph-
eral vascular disease and cerebrovascular disease, the interpre-
tation of invasive cardiac procedure use among these patients
may be misleading. In our CVD cohort, patients included
within the category of “other cardiovascular diseases” were
numerous, had heterogeneous diagnoses and accounted for
much of the variation in treatment between African Americans
and whites. b) The observed reversal in PTCA use may be
explained by recent research that has documented differences
Table 2. Unadjusted Procedure Rates for Cardiovascular Disease Cohort and Refined Cohorts
CVD Cohort
(n 5 1,406)
Local Cohort
(n 5 511)
IHD Cohort
(n 5 497)
AA
(n 5 211)
W
(n 5 1,195) OR 95% CI
AA
(n 5 169)
W
(n 5 342) OR 95% CI
AA
(n 5 40)
W
(n 5 457) OR 95%
CC 11% 25% 0.37* 0.24–0.58 11% 21% 0.47* 0.27–0.79 39 48 0.70 0.36–1.37
PTCA 2% 4% 0.60 0.25–1.49 3% 3% 1.11 0.38–3.20 13 10 1.36 0.52–3.53
CABG 1% 6% 0.22* 0.08–0.63 1% 4% 0.30 0.07–1.19 8 16 0.45 0.14–1.42
Any 11% 28% 0.32* 0.21–0.50 12% 22% 0.46* 0.27–0.78 42 57 0.55 0.28–1.06
*p , 0.01. AA 5 African American; CABG 5 coronary artery bypass graft surgery; CC 5 cardiac catheterization; CI 5 confidence interval; CVD 5 cerebrovascular
disease; IHD 5 ischemic heart disease; OR 5 odds ratio; PTCA 5 percutaneous transluminal coronary angioplasty; W 5 white.
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between African Americans and whites with regard to findings
during coronary angiography (15). This study found that
African Americans had less severe coronary artery occlusion
and a lower incidence of three-vessel disease than whites.
Thus, African Americans were considered less often for revas-
cularization procedures overall, and when considered for re-
vascularization, they were more likely than whites to undergo
PTCA but less likely to undergo CABG. Although we did not
investigate coronary angiographic results among our IHD
cohort, these previous findings suggest that local medical
decisions that were based on detailed anatomic information
may have led to appropriate racial differences in revascular-
ization procedure use.
4. When examining survival at 30 days and 1 year after index
hospital admission, we found that African Americans and
whites had nearly equivalent survival rates. Thus, observed
treatment differences did not translate into clinically significant
poorer survival among African Americans in this cohort (a
sample size of 4,800 patients would have been required to
detect a statistically significant difference in these survival rates
at a 0.05 significance level and 80% power). A similar obser-
vation has been previously reported among veterans admitted
Table 3. Demographic and Clinical Variables Among the
Roudebush Cardiovascular Disease Cohort by Procedure Use
Procedure
(n 5 362)
No Procedure
(n 5 1,044) p Value
Demographic variables
Mean age (yr) 61.6 64.5 ,0.01
Married (%) 65 56 ,0.01
Eligibility (%)
Nonservice 55 48 ,0.01
Service 27 25
Marion County residence (%) 27 40 ,0.01
Clinical variables
Previous amputation (%) 1 1 1
Previous CABG (%) 8 12 0.02
CHF (%) 19 31 ,0.01
Cerebrovascular disease (%) 6 10 ,0.01
Lung cancer (%) 1 2 0.06
Schizophrenia (%) 2 4 0.06
Dementia (%) 1 2 0.13
Renal disease (%) 14 35 ,0.01
Ascites (%) 0 2 ,0.01
Diabetes (%) 24 39 ,0.01
Any malignancy (%) 5 9 ,0.01
Plans for later CC (%) 3 1 ,0.01
Plans for later PTCA (%) 1 1 0.04
Plans for later CABG (%) 6 1 ,0.01
Plans for later stress test (%) 6 4 0.09
Refusal of ER treatment (%) 1 1 0.52
Refusal of inpatient treatment
(%)
8 11 0.27
CHF per chest X-ray film (%) 15 (n 5 362) 23 (n 5 1,044) ,0.01
COPD per chest X-ray film (%) 1 (n 5 362) 3 (n 5 1,044) ,0.04
BUN (mmol/liter) 6.4 (n 5 222) 7.5 (n 5 872) ,0.01
Creatinine clearance (ml/s) 1.3 (n 5 224) 1.1 (n 5 875) ,0.01
Serum creatinine (mmol/liter) 107 (n 5 224) 122 (n 5 875) 0.04
Serum albumin (g/liter) 40 (n 5 195) 38 (n 5 790) ,0.01
Fractional shortening by
echocardiogram
0.24 (n 5 96) 0.23 (n 5 366) 0.15
Left ventricular diameter (cm) 5.1 (n 5 107) 5.3 (n 5 400) 0.13
FEV1 (% predicted) 73 (n 5 50) 67 (n 5 233) 0.03
FVC (% predicted) 83 (n 5 54) 78 (n 5 256) 0.05
Weight (kg) 90.5 (n 5 171) 87.7 (n 5 622) 0.08
Ideal body weight (%) 116 (n 5 171) 112 (n 5 622) 0.03
Boldface indicates significant variables. BUN 5 blood urea nitrogen; CHF 5
congestive heart failure; COPD 5 chronic obstructive lung disease; ER 5
emergency room; FEV1 5 force expiratory volume in 1 s; FVC 5 forced vital
capacity; LV 5 left ventricular; n 5 number of patients with a measurement
obtained; other abbreviations as in Table 2.
Table 4. Demographic and Clinical Variables Among the
Roudebush Cardiovascular Disease Cohort by Race
African
American
(n 5 204)
White
(n 5 1,202) p Value
Demographic variables
Mean age (yr) 63.3 63.9 0.51
Married (%) 44 61 ,0.01
Eligibility
Nonservice (%) 36 48 ,0.01
Service (%) 20 22
Marion County residence (%) 84 29 ,0.01
Clinical variables
Previous amputation (%) 1 1 0.27
Previous CABG (%) 8 11 0.23
CHF (%) 32 27 0.15
Cerebrovascular disease (%) 12 9 0.11
Lung cancer (%) 5 1 ,0.01
Schizophrenia (%) 7 3 ,0.01
Dementia (%) 3 1 0.02
Renal disease (%) 49 26 ,0.01
Ascites (%) 3 2 0.14
Diabetes (%) 44 34 ,0.01
Any malignancy (%) 11 7 0.09
Plans for later CC (%) 1 1 1
Plans for later PTCA (%) 0 1 1
Plans for later CABG (%) 1 2 0.33
Plans for later stress test (%) 4 4 1
Refusal of ER treatment (%) 2 1 0.20
Refusal of inpatient treatment
(%)
10 10 1
CHF per chest X-ray film (%) 22 (n 5 204) 21 (n 5 1202) 0.64
COPD per chest X-ray film (%) 3 (n 5 204) 3 (n 5 1202) 0.71
BUN (mmol/liter) 8.9 (n 5 177) 7.1 (n 5 917) ,0.01
Creatinine clearance (ml/s) 1.0 (n 5 177) 1.2 (n 5 922) ,0.01
Serum creatinine (mmol/liter) 206 (n 5 177) 107 (n 5 922) ,0.01
Serum albumin (g/liter) 37 (n 5 161) 39 (n 5 824) ,0.01
Fractional shortening by
echocardiogram
0.24 (n 5 74) 0.23 (n 5 388) 0.50
LV diameter (cm) 5.22 (n 5 80) 5.24 (n 5 427) 0.87
FEV1 (% predicted) 63 (n 5 38) 68 (n 5 245) 0.13
FVC (% predicted) 69 (n 5 42) 80 (n 5 268) ,0.01
Weight (kg) 84.5 (n 5 128) 88.6 (n 5 665) 0.04
Ideal body weight (%) 109 (n 5 128) 114 (n 5 665) 0.05
Boldface indicates significant variables. Abbreviations as in Tables 2 and 3.
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for care of an acute myocardial infarction (3). Taken together,
these results serve to remind us that we must not rely on
process of care measures as surrogates for quality of care
measures.
Study limitations. Our study has important limitations: 1)
Our sample size precluded us from performing anticipated
multivariate analyses. Therefore, our reported racial differ-
ences in invasive cardiac procedure use and the observed
effects of cohort modification are unadjusted for clinically
relevant demographic and clinical variables. We can only
speculate at this time whether the observed clinical differences
had any legitimate impact on cardiac procedure use. 2) Even
with the expanded clinical data available through the RMRS
and chart audits, our retrospective design limited the com-
pleteness and accuracy of all potential data elements. We were
unable to ascertain patient preferences for cardiac care, could
not determine cardiac disease symptom severity and could not
assess directly physicians’ clinical decision-making factors with
regard to invasive cardiac procedure recommendations. Unde-
tected inaccuracies or misclassifications of recorded data likely
reduced our ability to detect additional clinical differences,
even if truly present. 3) Our data originate from one DVA
institution, which limits the generalizability of our findings.
Veterans have been shown to be sociodemographically differ-
ent from other patient populations; therefore, extrapolation of
these findings to other settings should be done with caution,
particularly in settings that provide care to women. However,
our overall results do appear to be strikingly similar to previous
studies within the DVA, which suggests that our institution is
not significantly different from others within this health care
system.
Conclusions. Although invasive cardiac procedure use was
significantly lower among African Americans than among their
white counterparts, these treatment differences did not lead to
clinically significant differences in survival. Our data suggest
that potential explanatory factors for treatment disparity in-
clude the presence of more severe comorbid disease among
African Americans and limitations of study designs that have
not controlled for referral status and specified cardiac diag-
noses. These findings provide hypotheses that must be tested in
future investigations. These studies should use prospective,
multisite designs that account for the patients’ preferences for
care, referral patterns and cardiac and noncardiac disease
severity, which specifically address the appropriateness of
invasive cardiac procedure use.
Appendix
Definition of Discharge Diagnoses and Dependent
and Independent Variables (by International
Classification of Diseases, 9th Revision, Clinical
Modification [ICD-9-CM] code)
Definition of Discharge Diagnoses
Rheumatic fever (390–392), rheumatic heart disease (393–398), hy-
pertensive disease (401–405), ischemic heart disease (410–414), pul-
monary circulation (415–417), other heart disease (420–429), cerebro-
vascular disease (430–438), disease of circulatory system (440–459),
chest pain (786.5–786.59).
Definition of Variables
Dependent variables (by ICD-9-CM procedure code)
Cardiac catheterization: 37.21–37.23, 88.55–88.57; percutaneous
transluminal coronary angioplasty: 36.00–36.03, 36.05–36.09; coronary
artery bypass graft surgery: 36.10–36.19.
Independent variables
Comorbid diagnoses that may affect coronary artery disease man-
agement, such as human immunodeficiency virus disease; cancer,
except nonmelanoma skin cancer; end-stage renal disease; cirrhosis;
dementia; psychiatric illness; alcohol and drug abuse, excluding to-
bacco; chronic lung disease; stroke; peripheral vascular disease; and
congestive heart failure.
Marital status was categorized as divorced, married, never married,
separated, widowed or unknown.
Entitlement status was categorized as category A service con-
nected, category A non-service connected or other.
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